Diagonal Bio AB Annual Report 2023

REG

Documents

 

  • Diagonal Bio AB Annual Report 2023
  • PR – Diagonal Bio AB Annual Report 2023 – 2024-05-15

 

For more information, please contact:

Karin Wehlin, VD

Phone: +46 (0)70305 24 88

E-mail: kw@diagonalbio.com

 

Certified Adviser

Svensk Kapitalmarknadsgranskning AB

E-mail: ca@skmg.se

 

About Diagonal Bio

Diagonal Bio AB was founded in 2020 and is a Swedish biotechnology company with headquarters and offices in Lund. The Company develops the PANVIRAL® platform to detect and diagnose small sections of pathogen genomes, for example viruses, bacteria and fungi. The Company was founded with the goal of reducing human suffering by revolutionizing global diagnostics of pathogen-borne diseases with proprietary technology. Diagonal Bio's patented technology can also be used for the less regulated market segments via LAMPlify®.

 

 

Datum 2024-05-15, kl 10:42
Källa Cision
Kom igång med ditt sparande på bara några minuter! Hos Avanza handlar du aktier från 0 kr på Stockholmsbörsen och får tillbaka alla fondavgifter (ja, alla!) upp till 50 000 kr i samlat sparande. Kanske är det därför Avanza har Sveriges nöjdaste sparare 15 år i rad.
Investeringar innebär en risk